Every laboratory has denials. The more useful question is why your laboratory keeps having the same ones.
Medical Billing / RCM | Genomic Testing | Laboratory
The AMP 2026 Annual Meeting & Expo runs November 10 to 14 in Seattle, with the main program November 12 to 14. The ADS lab team will be in Booth #1901. Molecular lab leaders will spend three days on new assays, sequencing workflows and what comes next in precision diagnostics. The science gets the spotlight. The billing decides whether those tests get paid. If you are heading to Seattle, here are five questions worth bringing with you, and worth answering before your next payer audit.
The Importance of Patient Engagement: Why They - And You - Need It
Learn why patient engagement is a necessity and how you can master it within your practice.
Your lab processed ten thousand claims this month. A few hundred came back denied, not for bad science, but for a documentation gap nobody caught until the remit arrived.
Medical Billing / RCM | Laboratory
Molecular diagnostics continues to change what is possible in medicine. Genetic testing, next generation sequencing, biomarker testing and other advanced diagnostics are giving clinicians increasingly sophisticated information to help diagnose disease, guide treatment and support precision medicine.
The final quarter of 2026 is here, and laboratories have plenty to think about before January.
Medical Billing / RCM | Laboratory
Losing revenue between the order and the deposit? See how ADS laboratory billing software checks claims before they go out. Your lab just posted its best test volume in three years. Collections didn't keep pace. Somewhere between the order and the deposit, revenue is leaking through modifier errors, LCD mismatches, and claims that never cleared a payer edit. Nobody on staff has time to trace where.
Your lab ran the panel correctly. The science isn't in question. But the claim came back denied because a Z-code was missing, and now your compliance manager is wondering if this is a billing problem or the start of something bigger. In 2026, it's often both.
Independent clinical laboratories spent much of 2026 preparing for one major date: July 31. That was the close of the latest PAMA private payer reporting window. Applicable laboratories submitted rate and volume information that CMS will use to help establish Clinical Laboratory Fee Schedule payment rates for 2027 through 2029.
A laboratory receives a denial. Someone investigates it, corrects it, resubmits or appeals it, and eventually gets it paid. Then another claim gets denied for the same reason next month. That is not a billing win. It is expensive repetition. As independent laboratories prepare for 2027, one of the biggest opportunities is not simply working denials faster. It is preventing more of them before they happen.
Looking for laboratory billing software or RCM services? Visit our Laboratory Solutions page → to see how ADS supports labs like yours. For the past several months, independent laboratories across the country have been focused on one milestone:the July 31 PAMA reporting deadline. Finance teams gathered private payer data, laboratory leadership reviewed reimbursement information, and billing departments submitted the required reporting to CMS under the Protecting Access to Medicare Act.